Role	0	4	O
of	5	7	O
thrombin	8	16	B-Gene_or_gene_product
in	17	19	O
angiogenesis	20	32	O
and	33	36	O
tumor	37	42	B-Pathological_formation
progression	43	54	O
.	54	55	O

Clinical	57	65	O
,	65	66	O
laboratory	67	77	O
,	77	78	O
histopathological	79	96	O
,	96	97	O
and	98	101	O
pharmacological	102	117	O
evidence	118	126	O
support	127	134	O
the	135	138	O
notion	139	145	O
that	146	150	O
the	151	154	O
coagulation	155	166	O
system	167	173	O
,	173	174	O
which	175	180	O
is	181	183	O
activated	184	193	O
in	194	196	O
most	197	201	O
cancer	202	208	B-Pathological_formation
patients	209	217	B-Organism
,	217	218	O
plays	219	224	O
an	225	227	O
important	228	237	O
role	238	242	O
in	243	245	O
tumor	246	251	B-Pathological_formation
biology	252	259	O
.	259	260	O

Our	261	264	O
laboratory	265	275	O
has	276	279	O
provided	280	288	O
evidence	289	297	O
that	298	302	O
thrombin	303	311	B-Gene_or_gene_product
activates	312	321	O
angiogenesis	322	334	O
,	334	335	O
a	336	337	O
process	338	345	O
which	346	351	O
is	352	354	O
essential	355	364	O
in	365	367	O
tumor	368	373	B-Pathological_formation
growth	374	380	O
and	381	384	O
metastasis	385	395	O
.	395	396	O

This	397	401	O
event	402	407	O
is	408	410	O
independent	411	422	O
of	423	425	O
fibrin	426	432	B-Gene_or_gene_product
formation	433	442	O
.	442	443	O

At	444	446	O
the	447	450	O
cellular	451	459	O
level	460	465	O
many	466	470	O
actions	471	478	O
of	479	481	O
thrombin	482	490	B-Gene_or_gene_product
can	491	494	O
contribute	495	505	O
to	506	508	O
activation	509	519	O
of	520	522	O
angiogenesis	523	535	O
:	535	536	O
(	537	538	O
1	538	539	O
)	539	540	O
.	540	541	O

Thrombin	542	550	B-Gene_or_gene_product
decreases	551	560	O
the	561	564	O
ability	565	572	O
of	573	575	O
endothelial	576	587	B-Cell
cells	588	593	I-Cell
to	594	596	O
attach	597	603	O
to	604	606	O
basement	607	615	B-Cellular_component
membrane	616	624	I-Cellular_component
proteins	625	633	O
.	633	634	O

(	635	636	O
2	636	637	O
)	637	638	O
.	638	639	O

Thrombin	640	648	B-Gene_or_gene_product
greatly	649	656	O
potentiates	657	668	O
vascular	669	677	B-Gene_or_gene_product
endothelial	678	689	I-Gene_or_gene_product
growth	690	696	I-Gene_or_gene_product
factor	697	703	I-Gene_or_gene_product
-	703	704	O
(	705	706	O
VEGF	706	710	B-Gene_or_gene_product
-	710	711	O
)	711	712	O
induced	713	720	O
endothelial	721	732	B-Cell
cell	733	737	I-Cell
proliferation	738	751	O
.	751	752	O

This	753	757	O
potentiation	758	770	O
is	771	773	O
accompanied	774	785	O
by	786	788	O
up	789	791	O
-	791	792	O
regulation	792	802	O
of	803	805	O
the	806	809	O
expression	810	820	O
of	821	823	O
VEGF	824	828	B-Gene_or_gene_product
receptors	829	838	O
(	839	840	O
kinase	840	846	B-Gene_or_gene_product
insert	847	853	I-Gene_or_gene_product
domain	854	860	I-Gene_or_gene_product
-	860	861	I-Gene_or_gene_product
containing	861	871	I-Gene_or_gene_product
receptor	872	880	I-Gene_or_gene_product
[	881	882	O
KDR	882	885	B-Gene_or_gene_product
]	885	886	O
and	887	890	O
fms	891	894	B-Gene_or_gene_product
-	894	895	I-Gene_or_gene_product
like	895	899	I-Gene_or_gene_product
tyrosine	900	908	I-Gene_or_gene_product
kinase	909	915	I-Gene_or_gene_product
[	916	917	O
Flt	917	920	B-Gene_or_gene_product
-	920	921	I-Gene_or_gene_product
1	921	922	I-Gene_or_gene_product
]	922	923	O
)	923	924	O
.	924	925	O

(	926	927	O
3	927	928	O
)	928	929	O
.	929	930	O

Thrombin	931	939	B-Gene_or_gene_product
increases	940	949	O
the	950	953	O
mRNA	954	958	O
and	959	962	O
protein	963	970	O
levels	971	977	O
of	978	980	O
alpha	981	986	B-Gene_or_gene_product
(	987	988	I-Gene_or_gene_product
v	988	989	I-Gene_or_gene_product
)	989	990	I-Gene_or_gene_product
beta	990	994	I-Gene_or_gene_product
(	995	996	I-Gene_or_gene_product
3	996	997	I-Gene_or_gene_product
)	997	998	I-Gene_or_gene_product
integrin	999	1007	I-Gene_or_gene_product
and	1008	1011	O
serves	1012	1018	O
as	1019	1021	O
a	1022	1023	O
ligand	1024	1030	O
to	1031	1033	O
this	1034	1038	O
receptor	1039	1047	O
.	1047	1048	O

Furthermore	1049	1060	O
,	1060	1061	O
thrombin	1062	1070	B-Gene_or_gene_product
increases	1071	1080	O
the	1081	1084	O
secretion	1085	1094	O
of	1095	1097	O
VEGF	1098	1102	B-Gene_or_gene_product
and	1103	1106	O
enhances	1107	1115	O
the	1116	1119	O
expression	1120	1130	O
and	1131	1134	O
protein	1135	1142	O
synthesis	1143	1152	O
of	1153	1155	O
matrix	1156	1162	B-Gene_or_gene_product
metalloprotease	1163	1178	I-Gene_or_gene_product
-	1178	1179	I-Gene_or_gene_product
9	1179	1180	I-Gene_or_gene_product
and	1181	1184	O
alpha	1185	1190	B-Gene_or_gene_product
(	1191	1192	I-Gene_or_gene_product
v	1192	1193	I-Gene_or_gene_product
)	1193	1194	I-Gene_or_gene_product
beta	1194	1198	I-Gene_or_gene_product
(	1199	1200	I-Gene_or_gene_product
3	1200	1201	I-Gene_or_gene_product
)	1201	1202	I-Gene_or_gene_product
integrin	1203	1211	I-Gene_or_gene_product
in	1212	1214	O
human	1215	1220	B-Organism
prostate	1221	1229	B-Cell
cancer	1230	1236	I-Cell
PC	1237	1239	I-Cell
-	1239	1240	I-Cell
3	1240	1241	I-Cell
cells	1242	1247	I-Cell
.	1247	1248	O

These	1249	1254	O
results	1255	1262	O
could	1263	1268	O
explain	1269	1276	O
the	1277	1280	O
angiogenic	1281	1291	O
and	1292	1295	O
tumor	1296	1301	B-Pathological_formation
-	1301	1302	O
promoting	1302	1311	O
effect	1312	1318	O
of	1319	1321	O
thrombin	1322	1330	B-Gene_or_gene_product
and	1331	1334	O
provide	1335	1342	O
the	1343	1346	O
basis	1347	1352	O
for	1353	1356	O
development	1357	1368	O
of	1369	1371	O
thrombin	1372	1380	B-Gene_or_gene_product
receptor	1381	1389	I-Gene_or_gene_product
mimetics	1390	1398	O
or	1399	1401	O
antagonists	1402	1413	O
for	1414	1417	O
therapeutic	1418	1429	O
application	1430	1441	O
.	1441	1442	O

